knowledge -WSS

knowledge

author：explore 2025-10-01 00:47:44 - browse：21282

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Private equity could exacerbate cardiology's overuse problem, experts fear

focus

leisure time

WSS

How housing is health care on Long Island

Diverse clinical trials: Why aren’t we there yet?

Paxlovid should be available without a positive Covid test

WATCH: Why do bright lights make us see spots?

After a drawn out lobbying fight, ARPA

Popular nasal decongestant doesn't actually relieve congestion

entertainment

knowledge

knowledge

New air purifier tech could be key to improving indoor air quality

WHO recommends dropping component of many flu vaccines

Novavax promises a turnaround & Lilly roils the obesity market

Medicaid, Medicare dual

Activists slam private health insurers over coverage restrictions

Telehealth for opioid use disorder is lifesaving

DIEP, the 'gold standard' of breast reconstruction, is under threat

Long Covid needs a new name — and a new frame

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ionis has late

Wikipedia

Menendez indictment could see pharma lose a key ally

New weight loss drugs vying to be the next Wegovy or Mounjaro

Menendez indictment could see pharma lose a key ally

Will the IRA bring competition to the biologics market?

Researchers use wearables data and AI to predict preterm birth risk

IRA could hurt research into orphan drugs for rare diseases

entertainment

focus

leisure time

knowledge